Erste Asset Management Gmb H Sarepta Therapeutics, Inc. Put Options Transaction History
Erste Asset Management Gmb H
- $10.3 Trillion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
418Shares Held
89.1MCall Options Held
5.86MPut Options Held
4.24M-
Vanguard Group Inc Valley Forge, PA10.8MShares$193 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$184 Million0.04% of portfolio
-
State Street Corp Boston, MA4.7MShares$83.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$79.8 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.65MShares$47.2 Million0.07% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.56B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...